Her2-pos Breast Ca: Herceptin (trastuzumab) is indicated for Her2-pos metastatic BC. Duration of therapy in metastatic setting is not well defined. Usually it continues as long as it works or discontinued due to toxicity. Zometa is indicated for bone metastasis in most solid tumors. It carries a risk for osteonecrosis of jaw. Usually it is stopped after 2 yrs if not earlier. Femara is for post-menopausal BC who has positive ER/PR.
Answered 3/13/2015
3.1k views
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
5 doctors weighed in across 3 answers
5 doctors weighed in across 3 answers
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question